Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 6, 2005Allergy

Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

View Full Paper
Ask AI
Bookmark
Share

Authors

JOJ OldhoffUniversity Medical Center GroningenUDUlf DarsowTechnical University of MunichTWThomas WerfelUniversity of Mississippi Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Oldhoff et al. (2005) studied this question.

synapsesocial.com/papers/6a717e69febe604dd70a22cdhttps://doi.org/10.1111/j.1398-9995.2005.00791.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects1997 · 98 citations
  2. 2Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic Dermatitis2009 · 1,052 citations
  3. 3Interleukin-5, eosinophils, and disease1992 · 789 citations
  4. 4In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals1992 · 124 citations
  5. 5Diagnostic Features of Atopic Dermatitis1980 · 5,130 citations